National Kidney Foundation's primer on kidney diseases / Scott Gilbert, Daniel E. Weiner ; associate editors, Andrew S. Bomback, Mark A. Perazella, Dena E. Rifkin.

<P>Structure and Function of the Kidney</p> <p>1. Overview of Kidney Structure and Function</p> <p>2. Kidney development</p> <p>3. Assessment of Kidney Function in Acute and Chronic Settings </p> <p>4. Urinalysis and Urine Microscopy </p> <p>5. Hematuria and Proteinuria</p> <p>6. Imaging the Kidneys</p> <p>Acid/Base and Electrolytes</p> <p>7. Hyponatremia and Hypoosmolar Disorders</p> <p>8. Hypernatremia</p> <p>9. Volume, Edema and the Clinical Use of Diuretics</p> <p>10. Disorders of Potassium Metabolism</p> <p>11. Disorders of Calcium, Phosphorus, & Magnesium Homeostasis</p> <p>12. Approach to Acid-Base Disorders</p> <p>13. Metabolic Acidosis</p> <p>14. Metabolic Alkalosis</p> <p>15. Respiratory Acidosis and Alkalosis</p> <p>Glomerular Diseases</p> <p>16. Glomerular Clinicopathologic Syndromes</p> <p>17. Minimal Change Nephrotic Syndrome</p> <p>18. Focal Segmental Glomerulosclerosis</p> <p>19. Membranous Nephropathy</p> <p>20. Immunoglobulin A Nephropathy and Related Disorders</p> <p>Kidney in Systemic Diseases</p> <p>21. COMPLEMENT-MEDIATED GLOMERULONEPHRITIS AND THROMBOTIC MICROANGIOPATHY </p> <p>22. Infection-related Glomerulonephritis</p> <p>23. Viral Nephropathies: Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus </p> <p>24. Kidney Involvement in Systemic Vasculitis</p> <p>25. Systemic Lupus Erythematosus and the Kidney</p> <p>26. Pathogenesis, Pathophysiology, and Treatment of Diabetic Nephropathy</p> <p>27. The Kidney in Malignancy</p> <p>28. Myeloma, Amyloid and other Dysproteinemias</p> <p>29. Acute Cardiorenal Syndrome </p> <p>30. Hepatorenal Syndrome and Other Liver-Related Kidney Diseases</p> <p>Acute Kidney Injury</p> <p>31. Clinical Approach to the Diagnosis of Acute Kidney Injury</p> <p>32. Acute Tubular Injury and Acute Tubular Necrosis</p> <p>33. Acute Interstitial Nephritis</p> <p>34. Management of Acute Kidney Injury</p> <p>Drugs and the Kidney</p> <p>35. Kidney Disease Caused by Therapeutic Agents</p> <p>36. Principles of Drug Therapy in Patients with Reduced Kidney Function</p> <p>Hereditary Kidney Disease</p> <p>37. Genetics and Kidney Disease (APOL1)</p> <p>38. Genetically Based Renal Transport Disorders</p> <p>39. Sickle Cell Nephropathy</p> <p>40. Polycystic and Other Cystic Kidney Diseases</p> <p>41. Nephronophthisis and Medullary Cystic Kidney Disease</p> <p>42. Alport's Syndrome and Thin Basement Membrane Dz</p> <p>43. Fabry Disease</p> <p>Tubulointerstitial Diseases</p> <p>44. Chronic Tubulointerstitial Disease</p> <p>45. Obstructive Uropathy</p> <p>46. Nephrolithiasis</p> <p>47. Urinary Tract Infection and Pyelonephritis</p> <p>Special Circumstances</p> <p>48. Kidney Diseases in Infants and Children</p> <p>49. The Kidney in Pregnancy</p> <p>50. Kidney Disease in the Elderly</p> <p>51. Global Kidney Disease</p> <p>Chronic Kidney Disease</p> <p>52. Development and Progression of Chronic Kidney Disease</p> <p>53. Staging and Management of Chronic Kidney Disease</p> <p>54. Nutrition and Kidney Disease</p> <p>55. Bone Disorders in Chronic Kidney Disease</p> <p>56. Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease</p> <p>57. Anemia and Other Hematologic Complications of Chronic Kidney Disease</p> <p>Dialysis and Transplantation</p> <p>58. Hemodialysis and Hemofiltration</p> <p>59. Peritoneal Dialysis</p> <p>60. Outcome of End-Stage Renal Disease Therapies</p> <p>61. Selection of Prospective Kidney Transplant Recipients and Donors</p> <p>62. Post-transplantation Monitoring and Outcomes</p> <p>63. Immunosuppression</p> <p>64. Transplant Infectious Disease</p> <p>Hypertension</p> <p>65. Pathogenesis of Hypertension</p> <p>66. Evaluation and Management of Hypertension</p> <p>67. Secondary Hypertension</p>

Includes bibliographical references.

Online resource; title from electronic title page (ClinicalKey, viewed July 1, 2022).

Elsevier Elsevier ClinicalKey eBooks - WAYFless access